Tuesday, February 27, 2018 12:41:43 PM
Been lurking for a while, but decided to come out and pitch a few cents of my own. I am with Les on this one. I began investing about a year ago and over the course of that year I have put in about 75k CAN into inmed and 35k into CHOOM, formally known as SGH. Choom alone, over the year, has put me into into 160k range when I pulled out and put back into Inmed. Granted, I should have waited a bit after New year's, but I am silly, what can I say. Either way, now I am sitting on over 500k shares of Inmed and despite a huge downfall of the weed stocks recently, i am still worth 400k-ish CAN. I have tried daytrading a small portion of inmed and stocks alike, making up to 15% in one trade on daily basis, but it is hard to keep it up over a long period of time due to these huge jumps back and forth. In either case, i am sticking with them long term, as in one year i am already up 300% (and at its peak was up 1000%). No amount of daytrading can beat that, especially with all the tax implications. I believe the tax laws are different in US, but for us canadians we have our capital gains taxed at 50% of what we earn from them, meanwhile daytrading counts as regular income and an entire portion in taxed. You can call these stocks a waste of time and rant your feelings away on the board, but everybody has a different approach to trading. If inmed is not working out for you, well sucks for you. But don't talk shit about it just because it isn't immediately producing results.
Recent INM News
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
- InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM
- InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial • Newsfile • 03/09/2026 11:30:00 AM
- InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline • Newsfile • 03/06/2026 10:04:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:58:07 PM
- InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 02/11/2026 10:23:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 10:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 04:55:06 PM
- InMed Announces Results of 2025 Annual General and Special Meeting • Newsfile • 12/18/2025 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 05:20:20 PM
